Matches in SemOpenAlex for { <https://semopenalex.org/work/W2515505027> ?p ?o ?g. }
- W2515505027 endingPage "57253" @default.
- W2515505027 startingPage "57239" @default.
- W2515505027 abstract "// Tejal Joshi 1, 2, * , Daniel Elias 1, 3, * , Jan Stenvang 1, 4 , Carla L. Alves 1, 3 , Fei Teng 1, 5 , Maria B. Lyng 1, 3 , Anne E. Lykkesfeldt 1, 6 , Nils Brünner 1, 4 , Jun Wang 1, 5 , Ramneek Gupta 1, 2 , Christopher T. Workman 2 , Henrik J. Ditzel 1, 3, 7 1 Sino-Danish Breast Cancer Research Centre, University of Copenhagen, Copenhagen, Denmark 2 Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kongens Lyngby, Denmark 3 Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark 4 Section of Molecular Disease Biology, Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark 5 BGI (Beijing Genomics Institute), Beishan Industrial Zone, Shenzhen, China 6 Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark 7 Department of Oncology, Odense University Hospital, Odense, Denmark * These authors have contributed equally to this work Correspondence to: Henrik J. Ditzel, email: hditzel@health.sdu.dk Christopher T. Workman, email: workman@cbs.dtu.dk Keywords: miRNAs, breast cancer, miRNA-mediated gene regulation, endocrine resistance, antihormonal therapy Abbreviations: DE, differentially expressed; logFC, log2-fold change Received: April 01, 2016 Accepted: July 27, 2016 Published: August 9, 2016 ABSTRACT Tamoxifen is an effective anti-estrogen treatment for patients with estrogen receptor-positive (ER+) breast cancer, however, tamoxifen resistance is frequently observed. To elucidate the underlying molecular mechanisms of tamoxifen resistance, we performed a systematic analysis of miRNA-mediated gene regulation in three clinically-relevant tamoxifen-resistant breast cancer cell lines (TamRs) compared to their parental tamoxifen-sensitive cell line. Alterations in the expression of 131 miRNAs in tamoxifen-resistant vs. parental cell lines were identified, 22 of which were common to all TamRs using both sequencing and LNA-based quantitative PCR technologies. Although the target genes affected by the altered miRNA in the three TamRs differed, good agreement in terms of affected molecular pathways was observed. Moreover, we found evidence of miRNA-mediated regulation of ESR1, PGR1, FOXM1 and 14-3-3 family genes. Integrating the inferred miRNA-target relationships, we investigated the functional importance of 2 central genes, SNAI2 and FYN, which showed increased expression in TamR cells, while their corresponding regulatory miRNA were downregulated. Using specific chemical inhibitors and siRNA-mediated gene knockdown, we showed that both SNAI2 and FYN significantly affect the growth of TamR cell lines. Finally, we show that a combination of 2 miRNAs (miR-190b and miR-516a-5p) exhibiting altered expression in TamR cell lines were predictive of treatment outcome in a cohort of ER+ breast cancer patients receiving adjuvant tamoxifen mono-therapy. Our results provide new insight into the molecular mechanisms of tamoxifen resistance and may form the basis for future medical intervention for the large number of women with tamoxifen-resistant ER+ breast cancer." @default.
- W2515505027 created "2016-09-16" @default.
- W2515505027 creator A5001467201 @default.
- W2515505027 creator A5001854115 @default.
- W2515505027 creator A5011720560 @default.
- W2515505027 creator A5014887333 @default.
- W2515505027 creator A5031780257 @default.
- W2515505027 creator A5040730315 @default.
- W2515505027 creator A5042241049 @default.
- W2515505027 creator A5051442267 @default.
- W2515505027 creator A5065198648 @default.
- W2515505027 creator A5067719774 @default.
- W2515505027 creator A5073078349 @default.
- W2515505027 creator A5082431102 @default.
- W2515505027 date "2016-08-09" @default.
- W2515505027 modified "2023-09-25" @default.
- W2515505027 title "Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer" @default.
- W2515505027 cites W1967084420 @default.
- W2515505027 cites W1970140424 @default.
- W2515505027 cites W1971735190 @default.
- W2515505027 cites W1975981804 @default.
- W2515505027 cites W1980680120 @default.
- W2515505027 cites W1982535740 @default.
- W2515505027 cites W1988800192 @default.
- W2515505027 cites W1994673501 @default.
- W2515505027 cites W2004102172 @default.
- W2515505027 cites W2013956549 @default.
- W2515505027 cites W2021145743 @default.
- W2515505027 cites W2026570544 @default.
- W2515505027 cites W2031189791 @default.
- W2515505027 cites W2037689491 @default.
- W2515505027 cites W2040191060 @default.
- W2515505027 cites W2050869737 @default.
- W2515505027 cites W2052132689 @default.
- W2515505027 cites W2063418528 @default.
- W2515505027 cites W2064511920 @default.
- W2515505027 cites W2065566217 @default.
- W2515505027 cites W2070417113 @default.
- W2515505027 cites W2073367400 @default.
- W2515505027 cites W2083381199 @default.
- W2515505027 cites W2084400739 @default.
- W2515505027 cites W2101117089 @default.
- W2515505027 cites W2102577097 @default.
- W2515505027 cites W2102803803 @default.
- W2515505027 cites W2116634113 @default.
- W2515505027 cites W2118728607 @default.
- W2515505027 cites W2133226725 @default.
- W2515505027 cites W2145126338 @default.
- W2515505027 cites W2150575159 @default.
- W2515505027 cites W2152239989 @default.
- W2515505027 cites W2159793493 @default.
- W2515505027 cites W2162468404 @default.
- W2515505027 cites W2164484108 @default.
- W2515505027 cites W2164864616 @default.
- W2515505027 cites W2166240615 @default.
- W2515505027 cites W2166695303 @default.
- W2515505027 cites W2167064590 @default.
- W2515505027 cites W2170989872 @default.
- W2515505027 cites W2405518779 @default.
- W2515505027 doi "https://doi.org/10.18632/oncotarget.11136" @default.
- W2515505027 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5302986" @default.
- W2515505027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27528030" @default.
- W2515505027 hasPublicationYear "2016" @default.
- W2515505027 type Work @default.
- W2515505027 sameAs 2515505027 @default.
- W2515505027 citedByCount "27" @default.
- W2515505027 countsByYear W25155050272017 @default.
- W2515505027 countsByYear W25155050272018 @default.
- W2515505027 countsByYear W25155050272019 @default.
- W2515505027 countsByYear W25155050272020 @default.
- W2515505027 countsByYear W25155050272021 @default.
- W2515505027 countsByYear W25155050272022 @default.
- W2515505027 countsByYear W25155050272023 @default.
- W2515505027 crossrefType "journal-article" @default.
- W2515505027 hasAuthorship W2515505027A5001467201 @default.
- W2515505027 hasAuthorship W2515505027A5001854115 @default.
- W2515505027 hasAuthorship W2515505027A5011720560 @default.
- W2515505027 hasAuthorship W2515505027A5014887333 @default.
- W2515505027 hasAuthorship W2515505027A5031780257 @default.
- W2515505027 hasAuthorship W2515505027A5040730315 @default.
- W2515505027 hasAuthorship W2515505027A5042241049 @default.
- W2515505027 hasAuthorship W2515505027A5051442267 @default.
- W2515505027 hasAuthorship W2515505027A5065198648 @default.
- W2515505027 hasAuthorship W2515505027A5067719774 @default.
- W2515505027 hasAuthorship W2515505027A5073078349 @default.
- W2515505027 hasAuthorship W2515505027A5082431102 @default.
- W2515505027 hasBestOaLocation W25155050271 @default.
- W2515505027 hasConcept C121608353 @default.
- W2515505027 hasConcept C126322002 @default.
- W2515505027 hasConcept C143998085 @default.
- W2515505027 hasConcept C2777176818 @default.
- W2515505027 hasConcept C29456083 @default.
- W2515505027 hasConcept C530470458 @default.
- W2515505027 hasConcept C71924100 @default.
- W2515505027 hasConcept C84606932 @default.
- W2515505027 hasConceptScore W2515505027C121608353 @default.
- W2515505027 hasConceptScore W2515505027C126322002 @default.
- W2515505027 hasConceptScore W2515505027C143998085 @default.